Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug | Synapse
March 3, 2026
Open Access
Cancer Immunology & Immunotherapy 2008: From Discovery to Development to Drug
Puntos clave
Cancer immunology has evolved to identify novel biomarkers for targeted therapies, enhancing immune response against tumors.
The review demonstrates how innovations in immunotherapy are transforming outcomes for patients with various cancer types.
Biomarkers play a crucial role in predicting response to therapies, guiding personalized treatment approaches.
The implications of this work could lead to more effective cancer treatments and improve patient survival rates.
Leer artículo completo
externamente
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Cite This Study
Copy
A Mon, study studied this question.
synapsesocial.com/papers/69a766adbadf0bb9e87ddf88
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo